Respiratory system agents

Study identifies most important inhaler technique errors that are linked to poor asthma outcomes

A study of 3,660 patients across eight countries has identified the types of inhaler technique errors that are associated with the greatest impact on asthma outcomes.…

A quick intervention recommendation by community pharmacists for patients using inhalers

Many pharmacists are probably busy reviewing inhaler use and technique as part of their medicines use reviews and new medicine service processes for patients with asthma and chronic obstructive pulmonary disease (COPD). The long-acting beta-2 agonist formoterol is a common ingredient in step-u…

Experts draw up new guidelines for treating COPD attacks

Give oral rather than intravenous corticosteroids to patients with chronic obstructive pulmonary disease flare-ups, say new guidelines.…

Panic over “symptomatuc refief” for throat problems

The reported shortage of a popular throat mixture has sent panic across the entertainment industry because of its popularity with actors, singers and performers.…

Asthma patients deserve better care

The 2016 Asthma UK annual asthma survey has produced some shocking findings. There are 5.4 million people in the UK diagnosed with asthma, but we found that two-thirds were not receiving the basic care that they need in order to stay well. This is worrying in the context that the majority of t…

The Pharmaceutical Journal’s most read opinion pieces of 2016

A round up of the most popular opinion pieces of 2016.…

Patients need training to use inhalers properly, study finds

Ellipta inhaler device comes out on top in GSK-sponsored research comparing several types of inhaler devices and their misuse among COPD and asthma patients.…

NICE recommends first asthma treatment to target eosinophils

Mepolizumab has been recommended as an add-on injectable treatment for severe refractory eosinophilic asthma in adults.…

Inadequate funding hampers research into chronic obstructive pulmonary disease

A lack of funding for research into chronic obstructive pulmonary disease, as well as difficulties in conducting clinical trials, make finding new treatments for this respiratory condition challenging. But there are glimmers of hope, such as reversing steroid resistance and identifying subpopulation…